Published in Biol Psychiatry on October 15, 1991
Probing GABA receptor function in schizophrenia with iomazenil. Neuropsychopharmacology (2010) 0.91
Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia. Annu Rev Clin Psychol (2013) 0.86
Obsessive-compulsive symptoms in chronic schizophrenia: a new idea or an old belief? Indian J Psychiatry (1997) 0.83
A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism. J Psychopharmacol (2008) 0.83
Serotonin, dopamine and their interactions in schizophrenia. Psychopharmacology (Berl) (1993) 0.78
Prolactin and psychopathology in schizophrenia: a literature review and reappraisal. Schizophr Res Treatment (2014) 0.75
The early identification of psychosis: can lessons be learnt from cardiac stress testing? Psychopharmacology (Berl) (2015) 0.75
The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine. Psychopharmacology (Berl) (1993) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry (1991) 5.36
Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry (1999) 3.69
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry (2007) 3.44
Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA (2000) 2.91
High cholesterol levels in patients with panic disorder. Am J Psychiatry (1992) 2.25
Quantitative genetic modeling of variation in human brain morphology. Cereb Cortex (2001) 2.24
Acute dystonia induced by drug treatment. BMJ (1999) 1.71
Wheat gluten as a pathogenic factor in schizophrenia. Science (1976) 1.69
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophr Res (2010) 1.68
Catatonia: disappeared or under-diagnosed? Psychopathology (2005) 1.64
Functional anatomical correlates of controlled and automatic processing. J Cogn Neurosci (2001) 1.60
Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res (1990) 1.59
The normalcy of self-proclaimed "normal volunteers". Am J Psychiatry (1989) 1.59
Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry (2000) 1.55
Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III. Am J Psychiatry (1998) 1.55
Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry (2005) 1.49
Multivariate genetic analysis of brain structure in an extended twin design. Behav Genet (2000) 1.49
Outcome of schizophrenia in relation to brain abnormalities. Schizophr Bull (1999) 1.46
Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand (2000) 1.45
[Depression following a first heart infarct; similarities with and differences from 'ordinary' depression]. Ned Tijdschr Geneeskd (1997) 1.43
Language lateralization in schizophrenia, an fMRI study. Schizophr Res (2001) 1.41
Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia (1993) 1.41
Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Arch Gen Psychiatry (1991) 1.41
[Mania: clinical aspects, cause and treatment]. Ned Tijdschr Geneeskd (1994) 1.40
Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology (2002) 1.40
An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Mol Psychiatry (2007) 1.38
Fluoxetine treatment of slow eating. J Clin Psychiatry (1992) 1.37
Test-retest reliability of fMRI activation during prosaccades and antisaccades. Neuroimage (2007) 1.36
Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage (2000) 1.32
Schizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands: evidence of an increased incidence. Psychol Med (1997) 1.31
Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry (1985) 1.30
Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry (2001) 1.27
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther (2007) 1.26
Health care reform and the special needs of children. Pediatrics (1994) 1.25
Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatry (2006) 1.23
Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophr Res (2002) 1.23
Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry (2006) 1.23
Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clin Pharmacol Ther (1974) 1.23
Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem Pharmacol (1971) 1.23
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl) (1999) 1.22
[A bifid uvula in a patient with schizophrenia as a sign of 22q11 deletion syndrome]. Ned Tijdschr Geneeskd (2002) 1.22
Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affect Disord (1987) 1.22
A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics. Psychopharmacologia (1975) 1.20
Prenatal exposure to famine and brain morphology in schizophrenia. Am J Psychiatry (2000) 1.19
Working memory capacity in schizophrenia: a parametric fMRI study. Schizophr Res (2004) 1.19
Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study. Lancet (1978) 1.19
Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings. Neurosci Biobehav Rev (2011) 1.18
Is there a relation between the seriousness of suicidal intent and the lethality of the suicide attempt? Psychiatry Res (1989) 1.18
New perspectives in the diagnosis of hepatitis C. Semin Liver Dis (1999) 1.18
Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatr Scand (2012) 1.17
Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol Psychiatry (1999) 1.14
Volumes of brain structures in twins discordant for schizophrenia. Arch Gen Psychiatry (2001) 1.14
Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychol Med (2005) 1.14
Contribution of residential exposures to asthma in us children and adolescents. Pediatrics (2001) 1.14
Investigating gene environment interaction in complex diseases: increasing power by selective sampling for environmental exposure. Int J Epidemiol (2007) 1.13
Childhood trauma and auditory verbal hallucinations. Psychol Med (2012) 1.11
Significance of positive and negative syndromes in chronic schizophrenia. Br J Psychiatry (1986) 1.09
Suicide assessment: clinical interview vs. self-report. J Clin Psychol (1994) 1.09
Combined analysis of language tasks in fMRI improves assessment of hemispheric dominance for language functions in individual subjects. Neuroimage (2001) 1.07
Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia. Psychiatry Res (1993) 1.07
Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res (2006) 1.07
Tardive dystonia. Schizophr Bull (1999) 1.07
Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr Scand (1981) 1.05
Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatr Scand (1993) 1.05
The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology (2000) 1.05
Language lateralization in monozygotic twin pairs concordant and discordant for handedness. Brain (2002) 1.05
Interconvertability of five self-report measures of depression. Psychiatry Res (1987) 1.04
A self-report measure of violence risk, II. Compr Psychiatry (1990) 1.04
Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol (2007) 1.03
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry (2015) 1.03
Language lateralization in female patients with schizophrenia: an fMRI study. Schizophr Res (2003) 1.01
The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I. Schizophr Res (1996) 1.01
The role of serotonin in schizophrenia. Schizophr Bull (1988) 1.00
The psychology of gastric bypass surgery. Obes Surg (2001) 1.00
Positive and negative syndromes in schizophrenia as a function of chronicity. Acta Psychiatr Scand (1986) 1.00
Prevalence of specific suicidal behaviors in a high school sample. Am J Psychiatry (1987) 1.00
Selective impairments in the stress response in schizophrenic patients. Psychopharmacology (Berl) (2000) 1.00
The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav (2007) 0.99
Significance of cocaine history in schizophrenia. J Nerv Ment Dis (1990) 0.99
Cerebral monoamines and depression. An investigation with the Probenecid technique. Arch Gen Psychiatry (1973) 0.99
Microstructural alterations of the arcuate fasciculus in schizophrenia patients with frequent auditory verbal hallucinations. Schizophr Res (2011) 0.99
Psychosis and brain volume changes during the first five years of schizophrenia. Eur Neuropsychopharmacol (2008) 0.99
Neuregulin 1: genetic support for schizophrenia subtypes. Mol Psychiatry (2004) 0.98
5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature (1970) 0.98
Management of depression with serotonin precursors. Biol Psychiatry (1981) 0.97
ECT in metropolitan New York hospitals: a survey of practice, 1975-1976. Am J Psychiatry (1978) 0.97
Maternal depression, child behavior, and injury. Inj Prev (2007) 0.97
Correlates of suicide and violence risk: III. A two-stage model of countervailing forces. Psychiatry Res (1989) 0.96
Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am J Psychiatry (1998) 0.96
Genetic influences on thinning of the cerebral cortex during development. Neuroimage (2011) 0.96
Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr Res (1998) 0.96
The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. Psychopharmacology (Berl) (1998) 0.96
A double hit implicates DIAPH3 as an autism risk gene. Mol Psychiatry (2010) 0.95
Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways. Mol Psychiatry (2009) 0.95
Brain morphology in antipsychotic-naïve schizophrenia: a study of multiple brain structures. Br J Psychiatry Suppl (2002) 0.94